18 November 2022 - Application submitted for Spikevax Bivalent Original / Omicron BA.4-5 (mRNA-1273.222)
Moderna Switzerland has submitted an application to Swissmedic for authorisation of a further bivalent COVID-19 vaccine.
Read Swissmedic press release